ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 36 filers reported holding ELIEM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,246 | -23.0% | 3,896 | -18.0% | 0.00% | – |
| Q2 2023 | $13,311 | +147800.0% | 4,754 | +45.7% | 0.00% | – |
| Q1 2023 | $9 | +350.0% | 3,262 | +408.1% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 642 | -34.6% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 981 | +123.0% | 0.00% | – |
| Q2 2022 | $1,000 | -95.0% | 440 | -81.9% | 0.00% | – |
| Q1 2022 | $20,000 | +100.0% | 2,431 | +142.9% | 0.00% | – |
| Q4 2021 | $10,000 | +11.1% | 1,001 | +103.9% | 0.00% | – |
| Q3 2021 | $9,000 | – | 491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,938,263 | $5,097,632 | 4.68% |
| RA Capital Management | 13,150,849 | $34,586,733 | 0.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 121,110 | $318,519 | 0.10% |
| Atom Investors LP | 78,886 | $207,470 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 811,680 | $2,134,718 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $145,789 | 0.00% |
| Chicago Partners Investment Group LLC | 12,806 | $32,785 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 29,704 | $78,122 | 0.00% |
| NORTHERN TRUST CORP | 11,182 | $29,409 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |